Roquefort Therapeutics Investor Relations Material
Latest events
H2 2024
29 Apr, 2025
H1 2024
27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Roquefort Therapeutics PLC
Access all reports
Roquefort Therapeutics PLC is a United Kingdom-based biotechnology company focused on developing novel therapies targeting cancer and autoimmune diseases. The company specializes in discovering and advancing small molecule and RNA-based therapeutics through its proprietary platforms. Its operations span early-stage research, preclinical testing, and strategic collaborations for drug development. Roquefort Therapeutics PLC is headquartered in London, United Kingdom, and its shares are listed on the LSE.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
ROQ
Country
🇬🇧 United Kingdom